Jeff Yass’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Other funds holding APGE
Jeff Yass's APGE Position: Q3 2026 in Review
Jeff Yass sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 27,256 shares — an estimated $3.62M sold.
Jeff Yass first reported a position in APGE in Q4 2023 and held it in 11 quarters. The position peaked at $3.62M in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.
- Jeff Yass reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
- Jeff Yass sold 27,256 Apogee Therapeutics shares in Q3 2026, an estimated $3.62M.
- Jeff Yass first reported a position in Apogee Therapeutics in Q4 2023 and held it in 11 quarters.
- Jeff Yass's Apogee Therapeutics position peaked at $3.62M in Q2 2026.
- 2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.